RS2 Healthcare Partners invests in KMM Group
The precision manufacturer is RS2’s first new platform investment since its healthcare rebrand.
RS2 Healthcare Partners has completed an investment in KMM Group, a Hatboro, Pennsylvania-based precision contract manufacturer serving medical device makers and other demanding markets. KMM produces complex, tight-tolerance components.
RS2 described it as its first new platform investment since refocusing on lower-middle-market healthcare investing. The firm appointed J.
Mark King president and CEO. Co-founders John Shegda and Eric Wilhelm remain in executive roles as chief technology officer and executive vice president for business transformation, respectively.
Get Buyout Desk email updates.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up on the site. Email updates are not on a fixed schedule.